CARBIOS (ALCRB.PA) Fundamental Analysis & Valuation

EPA:ALCRB • FR0011648716

Current stock price

7.9 EUR
-0.41 (-4.93%)
Last:

This ALCRB.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALCRB.PA Profitability Analysis

1.1 Basic Checks

  • ALCRB had negative earnings in the past year.
  • In the past year ALCRB has reported a negative cash flow from operations.
  • ALCRB had negative earnings in 4 of the past 5 years.
  • In the past 5 years ALCRB always reported negative operating cash flow.
ALCRB.PA Yearly Net Income VS EBIT VS OCF VS FCFALCRB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • ALCRB's Return On Assets of -16.01% is on the low side compared to the rest of the industry. ALCRB is outperformed by 84.72% of its industry peers.
  • With a Return On Equity value of -21.99%, ALCRB is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -16.01%
ROE -21.99%
ROIC N/A
ROA(3y)-11.97%
ROA(5y)-10.26%
ROE(3y)-16.77%
ROE(5y)-14.67%
ROIC(3y)N/A
ROIC(5y)N/A
ALCRB.PA Yearly ROA, ROE, ROICALCRB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

1.3 Margins

  • ALCRB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCRB.PA Yearly Profit, Operating, Gross MarginsALCRB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ALCRB.PA Health Analysis

2.1 Basic Checks

  • ALCRB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALCRB remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, ALCRB has more shares outstanding
  • ALCRB has about the same debt/assets ratio as last year.
ALCRB.PA Yearly Shares OutstandingALCRB.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ALCRB.PA Yearly Total Debt VS Total AssetsALCRB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • ALCRB has an Altman-Z score of 0.31. This is a bad value and indicates that ALCRB is not financially healthy and even has some risk of bankruptcy.
  • ALCRB's Altman-Z score of 0.31 is on the low side compared to the rest of the industry. ALCRB is outperformed by 86.11% of its industry peers.
  • A Debt/Equity ratio of 0.19 indicates that ALCRB is not too dependend on debt financing.
  • ALCRB has a Debt to Equity ratio of 0.19. This is in the better half of the industry: ALCRB outperforms 68.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 0.31
ROIC/WACCN/A
WACC7.03%
ALCRB.PA Yearly LT Debt VS Equity VS FCFALCRB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 3.84 indicates that ALCRB has no problem at all paying its short term obligations.
  • ALCRB's Current ratio of 3.84 is amongst the best of the industry. ALCRB outperforms 95.83% of its industry peers.
  • ALCRB has a Quick Ratio of 3.79. This indicates that ALCRB is financially healthy and has no problem in meeting its short term obligations.
  • ALCRB's Quick ratio of 3.79 is amongst the best of the industry. ALCRB outperforms 97.22% of its industry peers.
Industry RankSector Rank
Current Ratio 3.84
Quick Ratio 3.79
ALCRB.PA Yearly Current Assets VS Current LiabilitesALCRB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALCRB.PA Growth Analysis

3.1 Past

  • The earnings per share for ALCRB have decreased strongly by -17.78% in the last year.
  • Looking at the last year, ALCRB shows a very strong growth in Revenue. The Revenue has grown by 655.84%.
  • Measured over the past years, ALCRB shows a very negative growth in Revenue. The Revenue has been decreasing by -37.71% on average per year.
EPS 1Y (TTM)-17.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.12%
Revenue 1Y (TTM)655.84%
Revenue growth 3Y9.01%
Revenue growth 5Y-37.71%
Sales Q2Q%610.96%

3.2 Future

  • Based on estimates for the next years, ALCRB will show a very strong growth in Earnings Per Share. The EPS will grow by 27.01% on average per year.
  • ALCRB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 300.17% yearly.
EPS Next Y-0.64%
EPS Next 2Y13.56%
EPS Next 3Y8.07%
EPS Next 5Y27.01%
Revenue Next Year316.67%
Revenue Next 2Y356.44%
Revenue Next 3Y278.37%
Revenue Next 5Y300.17%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALCRB.PA Yearly Revenue VS EstimatesALCRB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
ALCRB.PA Yearly EPS VS EstimatesALCRB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALCRB.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALCRB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ALCRB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCRB.PA Price Earnings VS Forward Price EarningsALCRB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCRB.PA Per share dataALCRB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.56%
EPS Next 3Y8.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALCRB.PA Dividend Analysis

5.1 Amount

  • No dividends for ALCRB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALCRB.PA Fundamentals: All Metrics, Ratios and Statistics

CARBIOS

EPA:ALCRB (4/24/2026, 7:00:00 PM)

7.9

-0.41 (-4.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-08
Earnings (Next)N/A
Inst Owners15.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap133.59M
Revenue(TTM)582.00K
Net Income(TTM)-38.57M
Analysts40
Price Target12.24 (54.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 229.53
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB 1
EV/EBITDA N/A
EPS(TTM)-2.29
EYN/A
EPS(NY)-1.61
Fwd EYN/A
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)-1.79
OCFYN/A
SpS0.03
BVpS10.37
TBVpS7.9
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -16.01%
ROE -21.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-11.97%
ROA(5y)-10.26%
ROE(3y)-16.77%
ROE(5y)-14.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 213.71%
Cap/Sales 5553.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.84
Quick Ratio 3.79
Altman-Z 0.31
F-Score3
WACC7.03%
ROIC/WACCN/A
Cap/Depr(3y)437.01%
Cap/Depr(5y)449.88%
Cap/Sales(3y)53289.6%
Cap/Sales(5y)34828.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.12%
EPS Next Y-0.64%
EPS Next 2Y13.56%
EPS Next 3Y8.07%
EPS Next 5Y27.01%
Revenue 1Y (TTM)655.84%
Revenue growth 3Y9.01%
Revenue growth 5Y-37.71%
Sales Q2Q%610.96%
Revenue Next Year316.67%
Revenue Next 2Y356.44%
Revenue Next 3Y278.37%
Revenue Next 5Y300.17%
EBIT growth 1Y-17.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.13%
EBIT Next 3Y14.13%
EBIT Next 5Y34.22%
FCF growth 1Y-48.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.97%
OCF growth 3YN/A
OCF growth 5YN/A

CARBIOS / ALCRB.PA Fundamental Analysis FAQ

What is the fundamental rating for ALCRB stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALCRB.PA.


What is the valuation status for ALCRB stock?

ChartMill assigns a valuation rating of 0 / 10 to CARBIOS (ALCRB.PA). This can be considered as Overvalued.


Can you provide the profitability details for CARBIOS?

CARBIOS (ALCRB.PA) has a profitability rating of 0 / 10.